These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 69217)

  • 1. 15-keto-13,14-dihydroprostaglandin E2 concentrations in serum of patients with breast cancer.
    Powles TJ; Coombes RC; Neville AM; Ford HT; Gazet JC; Levine L
    Lancet; 1977 Jul; 2(8029):138. PubMed ID: 69217
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum kappa-casein in breast cancer.
    Woods RL; Searle F; Wilson P; Bagshawe KD; Cooper EH
    Eur J Cancer (1965); 1977 Oct; 13(10):1113-7. PubMed ID: 562759
    [No Abstract]   [Full Text] [Related]  

  • 3. A correlation of erythrocyte sedimentation and plasma carcinoembryonic antigen in fibrocystic disease and carcinoma of the breast.
    Thynne GS; Greening WP
    Clin Oncol; 1980 Dec; 6(4):317-21. PubMed ID: 7460405
    [No Abstract]   [Full Text] [Related]  

  • 4. Human benign breast disease: relationships between prostaglandin E2, steroid hormones, and thermographic effects of the inhibitors of PG biosynthesis.
    Rolland PH; Martin PM; Bourry M; Rolland AM; Serment H
    Adv Prostaglandin Thromboxane Res; 1980; 6():581-4. PubMed ID: 7386292
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prolactin. Radioimmunoassay in female breast cancers and benign mastopathies].
    Gorins A; Netter A
    Nouv Presse Med; 1974 Jan; 3(2):73-5. PubMed ID: 4815434
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast cancer and benign breast disease patients evaluated in relation to oxidative stress.
    Seven A; Erbil Y; Seven R; Inci F; Gülyaşar T; Barutçu B; Candan G
    Cancer Biochem Biophys; 1998 Nov; 16(4):333-45. PubMed ID: 9925281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The investigation of lactalbumin as a possible marker for human breast cancer.
    Woods KL; Cove DH; Morrison JM; Heath DA
    Eur J Cancer (1965); 1979 Jan; 15(1):47-51. PubMed ID: 421715
    [No Abstract]   [Full Text] [Related]  

  • 8. Carcinoembryonic antigen (CEA) in mammary disease: a clinical evaluation.
    Varnavides LA; O'Higgins NJ; Clark CG
    Clin Oncol; 1978 Dec; 4(4):329-37. PubMed ID: 729222
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum steroid binding proteins and the bioavailability of estradiol in relation to breast diseases.
    Langley MS; Hammond GL; Bardsley A; Sellwood RA; Anderson DC
    J Natl Cancer Inst; 1985 Nov; 75(5):823-9. PubMed ID: 3863985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of serum fucose levels in conglumeration with trans-sternal phlebography in the management of breast cancer.
    Mishra VK; Basu PK; Saxena SP; Prakash O
    Indian J Cancer; 1988 Jun; 25(2):77-83. PubMed ID: 3056851
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum oestradiol-17 beta in women with benign and malignant breast disease.
    England PC; Skinner LG; Cottrell KM; Sellwood RA
    Br J Cancer; 1974 Dec; 30(6):571-6. PubMed ID: 4447785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double antibody radioimmunoassay for monitoring metastatic breast cancer.
    Schecter RL; Major PP; Kovac PE; Ishida M; Kovalik EC; Dion AS; Langleben A; Boileau G; Boos G; Panasci L
    Br J Cancer; 1988 Sep; 58(3):362-7. PubMed ID: 3179189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative behavior of prostaglandin E2 and 13,14-dihydro-15-keto-PGF2 alpha in serum of bronchial carcinoma patients.
    Fiedler L; Zahradnik HP; Schlegel G
    Adv Prostaglandin Thromboxane Res; 1980; 6():585-6. PubMed ID: 7386293
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-protein bound oestradiol, sex hormone binding globulin, breast cancer and breast cancer risk.
    Bruning PF; Bonfrèr JM; Hart AA
    Br J Cancer; 1985 Apr; 51(4):479-84. PubMed ID: 4038881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum c-erbB-2 protein in breast cancer patients.
    Chearskul S; Sinlarat P; Bhothisuwan K; Churintrapun M; Ornrhebroi S; Klinsala N; Sungkabunchoo S
    J Med Assoc Thai; 2000 Aug; 83(8):886-93. PubMed ID: 10998842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of serum fucose, sialic acid, haptoglobine and phospholipids levels in the evolution and treatment of breast cancer.
    Kiricuta I; Bojan O; Comes R; Cristian R
    Arch Geschwulstforsch; 1979; 49(2):106-12. PubMed ID: 475547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
    Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
    Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum oestradiol in women with and without breast disease.
    Bennett IC; McCaffrey JF; McCaffrey E; Wyatt B
    Br J Cancer; 1990 Jan; 61(1):142-6. PubMed ID: 2393409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Prolactin in benign and malignant breast disease.
    Cole EN; England PC; Sellwood RA; Griffiths K
    J Endocrinol; 1976 Jun; 69(3):49P-50P. PubMed ID: 950543
    [No Abstract]   [Full Text] [Related]  

  • 20. Central venous concentrations of immunoreactive prostaglandins E, F, and 6-keto-prostaglandin F1 in eclampsia.
    Moodley J; Norman RJ; Reddi K
    Br Med J (Clin Res Ed); 1984 May; 288(6429):1487-9. PubMed ID: 6426613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.